scispace - formally typeset
D

Debora S. Marks

Researcher at Harvard University

Publications -  151
Citations -  25901

Debora S. Marks is an academic researcher from Harvard University. The author has contributed to research in topics: Protein structure & Biology. The author has an hindex of 49, co-authored 128 publications receiving 22195 citations. Previous affiliations of Debora S. Marks include University of Tübingen & University of Paris.

Papers
More filters
Journal ArticleDOI

Human MicroRNA Targets

TL;DR: This work has predicted target sites on the 3′ untranslated regions of human gene transcripts for all currently known 218 mammalian miRNAs to facilitate focused experiments and suggests that miRNA genes, which are about 1% of all human genes, regulate protein production for 10% or more of allhuman genes.
Journal ArticleDOI

MicroRNA targets in Drosophila

TL;DR: The results reaffirm the thesis that miRNAs have an important role in establishing the complex spatial and temporal patterns of gene activity necessary for the orderly progression of development and suggest additional roles in the function of the mature organism.
Journal ArticleDOI

The microRNA.org resource: targets and expression

TL;DR: The web resource provides users with functional information about the growing number of microRNAs and their interaction with target genes in many species and facilitates novel discoveries in microRNA gene regulation.
Journal ArticleDOI

Identification of Virus-Encoded MicroRNAs

TL;DR: The small RNA profile of cells infected by Epstein-Barr virus is recorded and it is shown that EBV expresses several microRNA (miRNA) genes, which are identified viral regulators of host and/or viral gene expression.
Journal ArticleDOI

Direct-coupling analysis of residue coevolution captures native contacts across many protein families

TL;DR: The findings suggest that contacts predicted by DCA can be used as a reliable guide to facilitate computational predictions of alternative protein conformations, protein complex formation, and even the de novo prediction of protein domain structures, contingent on the existence of a large number of homologous sequences which are being rapidly made available due to advances in genome sequencing.